Nuvista Pharma PLC is a Bangladeshi pharmaceutical company and a subsidiary of Beximco Pharma. It has operated in Bangladesh since 1964 and describes itself as the country's first specialised pharma company in the hormone and steroid market, with leadership in multiple therapeutic markets. Its stated mission is to create a healthier society through quality medicine, one doctor and one patient at a time.

The company was formerly Organon (Bangladesh), a subsidiary of Organon International, the human healthcare unit of Akzo Nobel in the Netherlands. Organon International divested the business in 2006 and it became Nuvista Pharma. In April 2018, Beximco Pharmaceuticals completed the acquisition of a majority (85.22%) stake in the company.

Nuvista is known for hormone and steroid medicines, with a strong focus on women's health, and for legacy multinational brands such as Traxyl, Marvelon, Ovostat Gold and Visceralgine. Its portfolio also covers gastroenterology, cardiovascular and other therapeutic areas, and it has a long-term manufacturing and marketing collaboration with Merck Sharp & Dohme (MSD). Its manufacturing facility is in Tongi.

Corporate office: Mirpur DOHS Cultural Centre, Road 9, Mirpur DOHS, Pallabi, Dhaka 1216, Bangladesh.